Jackson, David C.

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

Jackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C., Zeng, W., & Brown, L. E. (2004) · Proceedings of the National Academy of Sciences

Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches

Cited by 236

A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease

Deinema, L. A., Vingrys, A. J., Wong, C. Y., Jackson, D. C., Chinnery, H. R., & Downie, L. E. (2017) · Ophthalmology

Ocular Surface and Contact LensFatty Acid Research and Health

Cited by 160

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection

Chua, B. Y., Eriksson, E. M., Brown, L. E., Zeng, W., Gowans, E. J., Torresi, J., & Jackson, D. C. (2008) · Vaccine

Immunotherapy and Immune ResponsesHepatitis C virus research

Cited by 54

Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population

Zeng, W., Horrocks, K. J., Tan, A. C. L., Wong, C. Y., Chua, B. Y., & Jackson, D. C. (2020) · Vaccine

Immunotherapy and Immune ResponsesChemical Synthesis and Analysis

Cited by 4